MX354049B - Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados. - Google Patents

Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados.

Info

Publication number
MX354049B
MX354049B MX2014007256A MX2014007256A MX354049B MX 354049 B MX354049 B MX 354049B MX 2014007256 A MX2014007256 A MX 2014007256A MX 2014007256 A MX2014007256 A MX 2014007256A MX 354049 B MX354049 B MX 354049B
Authority
MX
Mexico
Prior art keywords
cloning
antibody variable
expression
variable region
gene segments
Prior art date
Application number
MX2014007256A
Other languages
English (en)
Other versions
MX2014007256A (es
Inventor
Seeber Stefan
Kopetzki Erhard
Hoege Simone
Ostler Dominique
Tiefenthaler Georg
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47522537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX354049(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2014007256A publication Critical patent/MX2014007256A/es
Publication of MX354049B publication Critical patent/MX354049B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un método como se reporta el aislamiento de segmentos de ácido nucleico que codifican para dominios variables de anticuerpo y la inserción de los segmentos aislados de ácido nucleico en plásmidos de expresión eucariótica se realiza sin el aislamiento y análisis intermedios de plásmidos clonales intermedios. De esta manera, en el método como se reporta en la presente, no se requieren la donación, aislamiento y análisis intermedios de plásmidos intermedios, por ejemplo, por análisis de células de E. coli, transformadas, aisladas.
MX2014007256A 2011-12-21 2012-12-19 Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados. MX354049B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11194861 2011-12-21
PCT/EP2012/076155 WO2013092716A1 (en) 2011-12-21 2012-12-19 Rapid method for cloning and expression of cognate antibody variable region gene segments

Publications (2)

Publication Number Publication Date
MX2014007256A MX2014007256A (es) 2014-08-01
MX354049B true MX354049B (es) 2018-02-09

Family

ID=47522537

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007256A MX354049B (es) 2011-12-21 2012-12-19 Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados.

Country Status (12)

Country Link
US (3) US20140302559A1 (es)
EP (1) EP2794652B1 (es)
JP (3) JP2015500655A (es)
KR (1) KR20140104963A (es)
CN (2) CN109810188A (es)
BR (1) BR112014013034A2 (es)
CA (1) CA2854243A1 (es)
HK (1) HK1199891A1 (es)
MX (1) MX354049B (es)
RU (1) RU2612910C2 (es)
SG (1) SG11201403365TA (es)
WO (1) WO2013092716A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5616428B2 (ja) 2009-04-07 2014-10-29 ロシュ グリクアート アクチェンゲゼルシャフト 三価の二重特異性抗体
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
WO2011034605A2 (en) 2009-09-16 2011-03-24 Genentech, Inc. Coiled coil and/or tether containing protein complexes and uses thereof
TW201138821A (en) 2010-03-26 2011-11-16 Roche Glycart Ag Bispecific antibodies
WO2012025530A1 (en) 2010-08-24 2012-03-01 F. Hoffmann-La Roche Ag Bispecific antibodies comprising a disulfide stabilized - fv fragment
JP5766296B2 (ja) 2010-12-23 2015-08-19 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
RU2607038C2 (ru) 2011-02-28 2017-01-10 Ф. Хоффманн-Ля Рош Аг Антигенсвязывающие белки
MX342034B (es) 2011-02-28 2016-09-12 Hoffmann La Roche Proteinas monovalentes que se unen a antigenos.
KR20140104963A (ko) * 2011-12-21 2014-08-29 에프. 호프만-라 로슈 아게 동족 항체 가변 영역 유전자 분절의 클로닝 및 발현을 위한 신속법
MX2014009565A (es) 2012-02-10 2014-11-10 Genentech Inc Anticuerpos monocatenarios y otros heteromultimeros.
ES2597228T3 (es) 2012-06-27 2017-01-17 F. Hoffmann-La Roche Ag Procedimiento para la selección y la producción de entidades de objetivación, como dianas, altamente selectivas y multiespecíficas, personalizadas, las cuales contienen por lo menos dos entidades de unión diferentes, y utilización de éstas
WO2014001325A1 (en) 2012-06-27 2014-01-03 F. Hoffmann-La Roche Ag Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof
US20160075766A1 (en) * 2013-05-21 2016-03-17 Roche Diagnostics Operations, Inc. Method for producing antibodies using ovine b-cells and uses thereof
BR112016006929A2 (pt) 2013-10-11 2017-09-19 Hoffmann La Roche Anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, métodos de preparação de anticorpo, de tratamento de pacientes e de geração de um anticorpo, composição farmacêutica e uso do anticorpo
JP6568207B2 (ja) * 2014-05-19 2019-08-28 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ヒツジｂ細胞を用いて抗体を産生するための方法およびその使用
PL3227332T3 (pl) 2014-12-03 2020-06-15 F. Hoffmann-La Roche Ag Wielospecyficzne przeciwciała
PL3436571T3 (pl) 2016-03-30 2023-09-25 F. Hoffmann-La Roche Ag Sposób hodowli limfocytów B
JP7360324B2 (ja) * 2016-12-23 2023-10-12 ビステラ， インコーポレイテッド 結合ポリペプチドおよびそれを作製する方法
EP3562936B1 (en) 2017-01-02 2024-05-22 F. Hoffmann-La Roche AG B-cell cultivation method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815909D0 (en) * 1998-07-21 1998-09-16 Btg Int Ltd Antibody preparation
CN100383244C (zh) * 2003-01-07 2008-04-23 西福根有限公司 用于生产重组多克隆蛋白质的方法
US20060051348A1 (en) 2004-09-09 2006-03-09 Jorn Gorlach Method of producing a plurality of isolated antibodies to a plurality of cognate antigens
WO2007031550A2 (en) 2005-09-15 2007-03-22 Crucell Holland B.V. Method for preparing immunoglobulin libraries
WO2008045140A1 (en) 2006-05-19 2008-04-17 Alder Biopharmaceuticals, Inc. Culture method for obtaining a clonal population of antigen-specific b cells
WO2008144763A2 (en) 2007-05-21 2008-11-27 Alder Biopharmaceuticals, Inc. Antibodies to il-6 and use thereof
WO2010056898A2 (en) 2008-11-12 2010-05-20 University Of Maryland, Baltimore Rapid expression cloning of human monoclonal antibodies from memory b cells
US8609097B2 (en) * 2009-06-10 2013-12-17 Hoffmann-La Roche Inc. Use of an anti-Tau pS422 antibody for the treatment of brain diseases
US20120302738A1 (en) * 2009-11-16 2012-11-29 Acyte Biotech Pty Ltd Recombinant antibody vector
WO2011112566A2 (en) * 2010-03-11 2011-09-15 Abbott Laboratories Basigin binding proteins
EP2400298B1 (en) 2010-05-28 2013-08-14 F.Hoffmann-La Roche Ag Single B-cell cultivation method and specific antibody production
KR20140104963A (ko) * 2011-12-21 2014-08-29 에프. 호프만-라 로슈 아게 동족 항체 가변 영역 유전자 분절의 클로닝 및 발현을 위한 신속법

Also Published As

Publication number Publication date
SG11201403365TA (en) 2014-07-30
JP2015500655A (ja) 2015-01-08
JP6573331B2 (ja) 2019-09-11
HK1199891A1 (en) 2015-07-24
RU2014128987A (ru) 2016-02-20
BR112014013034A2 (pt) 2017-12-19
WO2013092716A1 (en) 2013-06-27
KR20140104963A (ko) 2014-08-29
US20140302559A1 (en) 2014-10-09
JP2017221190A (ja) 2017-12-21
EP2794652A1 (en) 2014-10-29
RU2612910C2 (ru) 2017-03-13
JP2019162144A (ja) 2019-09-26
CN104011074A (zh) 2014-08-27
CN109810188A (zh) 2019-05-28
MX2014007256A (es) 2014-08-01
US20170210785A1 (en) 2017-07-27
US20190382469A1 (en) 2019-12-19
CA2854243A1 (en) 2013-06-27
EP2794652B1 (en) 2017-11-15

Similar Documents

Publication Publication Date Title
MX354049B (es) Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados.
CA3062698A1 (en) Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
MX355356B (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
EP4253534A3 (en) Alpha-amylase variants and polynucleotides encoding same
MX2015008446A (es) Composiciones de proteinas de union multivalentes.
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
MX337984B (es) Variantes de alfa amilasa y polinucleotidos que codifican la misma.
IN2014CN04586A (es)
MX2021000209A (es) Metodos y productos para transfeccion de celulas.
MX353621B (es) Variantes de alfa-amilasa.
EP3543333A3 (en) Method for screening alpha-amylases
MY170720A (en) Antibody formulations
EP3696265A3 (en) Lipase variants and polynucleotides encoding same
EP3517611A3 (en) Methods for preparative in vitro cloning
WO2013119302A3 (en) Gh61 polypeptide variants and polynucleotides encoding same
MX2020003508A (es) Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.
MX366112B (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
PH12019501001A1 (en) Method for preparing electrocompetent yeast cells, and method for using said cells
MX2014007446A (es) Variantes de subtilasa y polinucleotidos que las codifican.
WO2013040548A3 (en) Fluoride-responsive riboswitchs, fluoride transporters, and methods of use
WO2012096552A3 (ko) Ｒｅｘ１을 포함하는 세포 리프로그래밍 조성물 및 이를 이용한 유도 만능줄기세포 제조방법
WO2012109470A3 (en) Mutant luciferases
WO2012175745A9 (en) Cell secreted proteins for the treatment of myocardial infarction
MX336042B (es) Derivados de pirazol utiles como inhibidores de aldosterona sintasa.
WO2015117033A3 (en) Methods of increasing protein production in mammalian cells

Legal Events

Date Code Title Description
FG Grant or registration